Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Express Scripts
Healthtrust
Cantor Fitzgerald
Fuji
Daiichi Sankyo
Covington
US Army
Federal Trade Commission
McKinsey

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077070

« Back to Dashboard
NDA 077070 describes SOTALOL HYDROCHLORIDE, which is a drug marketed by Altathera Pharms Llc, Apotex, Sun Pharm Inds, Mylan, Beximco Pharms Usa, Teva, Watson Labs, Apotex Inc, Impax Pharms, Vintage Pharms, Upsher-smith Labs, and Epic Pharma Inc, and is included in sixteen NDAs. It is available from twenty-two suppliers. Additional details are available on the SOTALOL HYDROCHLORIDE profile page.

The generic ingredient in SOTALOL HYDROCHLORIDE is sotalol hydrochloride. There are ten drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the sotalol hydrochloride profile page.

Summary for NDA: 077070

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 077070

Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectCardiac Rhythm Alteration

Suppliers and Packaging for NDA: 077070

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SOTALOL HYDROCHLORIDE
sotalol hydrochloride
TABLET;ORAL 077070 ANDA Epic Pharma, LLC 42806-121 42806-121-01 100 TABLET in 1 BOTTLE (42806-121-01)
SOTALOL HYDROCHLORIDE
sotalol hydrochloride
TABLET;ORAL 077070 ANDA Epic Pharma, LLC 42806-121 42806-121-10 1000 TABLET in 1 BOTTLE (42806-121-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength80MG
Approval Date:Nov 4, 2005TE:AB2RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength120MG
Approval Date:Nov 4, 2005TE:AB2RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength160MG
Approval Date:Nov 4, 2005TE:AB2RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Cerilliant
Cipla
Healthtrust
McKesson
US Department of Justice
UBS
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot